Pacific Edge surged near a three-year high on its provisional return to Medicare cover.
Fledgling Kiwi company sees itself as consolidator for global market.
New boss axed 55 jobs at end of last year in $8m cost savings bid.
CEO Simon Mander says Covid is muddying company's prospects at present.
The NZX-listed honey, skincare, and supplements company has written down its newly-acquired honey business.
Company’s 12 dealerships restricted from fully operating for 108 days.
Underlying profit up 42% at the listed aged care business.
Building consents skyrocket - but do supply costs for glass maker.
The retirement operator recorded a full-year profit of $2.7m.
Newly-listed tech company reports higher revenue but wider loss for FY22.
